Wegovy highlights of prescribing information, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) Alcohol and diabetes, American Diabetes Association (2024) Rybelsus highlights of prescribing information, Food and Drug Administration (2024) Food sources of dietary fiber, Dietary Guidelines for Americans (2024) Semaglutide injection, MedlinePlus (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
However, tirzepatide 5 mg produced greater weight loss (-7.8 kg vs -5.7 kg), so it is not a true equivalency
Earlier this month, Danish pharma giant Novo Nordisk released the first GLP-1 pill for obesity, and rival Eli Lilly is planning to release its own version later this year
However, during an FDA-declared drug shortage, these medications can legally be compounded
Can I expect the same tanning results from both
And sure, weve had some people that have had an upward of 40 or 50 pounds to lose, but its really, its just, I think reaffirming to what my experience is seeing, who is coming and contacting us, but also us developing messaging and things based on what I know is huge